FDA Inspection 1285900 — Noven Pharmaceuticals, Inc.

Noven Pharmaceuticals, Inc. — FEI 1000222037

The FDA completed an inspection of Noven Pharmaceuticals, Inc. on Feb 13, 2026 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 13, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.